The CXCL13/CXCR5 axis not only modulates molecular events inside malignant cells to promote tumor initiation and progression, but also recruits multiple populations of lymphocytes to exert pro-tumor or anti-tumor immunity reactions in the TME. This evidence concerns the gene CXCR5 and neoplasm.